Stay updated on BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial

Sign up to get notified when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-07T09:28:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page shows revision v3.4.2 replacing v3.4.1. No study data or user-facing content appears to be changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T02:01:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page. No visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-02-06T16:41:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Glossary visibility controls were added (Show glossary / Hide glossary), and minor text updates adjust update-status labels and revision/version strings across the page.
    Difference
    0.4%
    Check dated 2026-01-23T10:10:24.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4; there are no substantive changes to study details, contacts, locations, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T06:16:00.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a consolidated 'Locations' section listing sites in AZ, FL, IN, OK, TX, Alberta, Newfoundland and Labrador, and Quebec, and removed the separate state/province location subsections. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure entry as well as the v3.3.2 note.
    Difference
    0.8%
    Check dated 2025-12-18T20:57:09.000Z thumbnail image

Stay in the know with updates to BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.